Here are relevant reports on : clinical-trial-recruitment-market
-
Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End user (Pharma & CROs) & Region - Global Forecast to 2030
The global central lab services/clinical trial lab services market, valued at US$5.64 billion in 2024, stood at US$5.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growth of the Asia Pacific central lab services/clinical trial lab services market can be attributed to the increasing prevalence of chronic diseases, such as cancer, kidney diseases, and CVDs.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
AI in Biotechnology Market by Function (Drug Design & Optimization, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply Chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events) and End User - Global Forecast to 2035
The global AI in biotechnology market, valued at US$3.51 billion in 2024, stood at US$4.16 billion in 2025 and is projected to advance at a resilient CAGR of 18.5% from 2024 to 2035, culminating in a forecasted valuation of US$22.72 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Proteomics Services Market by Service Type (Core Proteomics, Bioinformatics), Application (Clinical, Drug Discovery), End User (Biopharmaceuticals, Hospitals) - Global Forecast to 2030
The global proteomics services market, valued at US$8.06 billion in 2024, stood at US$8.77 billion in 2025 and is projected to advance at a resilient CAGR of 13.4% from 2025 to 2030, culminating in a forecasted valuation of US$16.46 billion by the end of the period. This growth is driven by advances in multiplexing, automation, and bioinformatics, which enable deeper analysis of protein interactions, biomarker discovery, and assay development, improving insights into therapeutic responses, diagnostics, and functional applications.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Plant Growth Chambers Market by Equipment Type (Reach-in, Walk-in), Application (Short Plants, Tall Plants), End Use (Clinical, Academic), Function (Plant Growth, Environmental Optimization), and Region - Global Forecast to 2022
The plant growth chambers market is projected to reach USD 485.6 Million by 2022 from USD 398.2 Million in 2017, growing at a CAGR of 4.0% during the forecast period. Increase in demand for food and technological advancements in biological engineering are some of the major factors that are expected to drive the demand for plant growth chambers. This report includes a study of various plant growth chambers, along with the product portfolios of leading companies. It includes the profiles of leading companies such as Thermo Fisher (US), Conviron (Canada), CARON (US), Percival Scientific (US), and BINDER (Germany).
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) - Global Forecasts to 2022
The protein assays market is projected to reach USD 2.41 Billion by 2022, at a CAGR of 11.1%. Some of the prominent players in the market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
The global continuous bioprocessing market, valued at US$201 million in 2022, stood at US$218 million in 2023 and is projected to advance at a resilient CAGR of 22.4% from 2023 to 2028, culminating in a forecasted valuation of US$599 million by the end of the period. The growth of the market is largely driven by rising demand for biopharmaceuticals, advantages of continuous bioprocessing over batch/fed-batch mode, and emergence of integrated end-to-end continuous bioprocessing.
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
The global Photoacoustic imaging market, valued at US$75M in 2023, is forecasted to grow at a 5.5% CAGR, reaching US$80M by 2024 and US$105M by 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Ready-To-Drink (RTD) Protein Beverages Market, By Source (Milk, whey, Casein, Egg, Soy, Rice), By Types (Weight Management Drinks, Clinical Drinks, Energy Drinks, Juice Drinks) - Trends & Forecast to 2018
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031
The global wearables in pharma & biotech market is projected to reach USD 9.97 billion by 2031, growing at a CAGR of 20.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) & Region
The global RSV diagnostics market is expected to grow at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).
- Published: February 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
